Literature DB >> 15478311

DISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness.

J Kirsty Millar1, Rachel James, Nicholas J Brandon, Pippa A Thomson.   

Abstract

A balanced (1;11)(q42;q14) translocation co-segregates with schizophrenia and major affective disorders in a large Scottish family. The translocation breakpoint on chromosome 1 is located within the Disrupted in Schizophrenia 1 and 2 genes (DISC1 and DISC2). Consequently loss of normal function of these genes is likely to underlie the susceptibility to developing psychiatric disorders that is conferred by inheritance of the translocation. Additionally, a number of independent genetic studies highlight the region of chromosome 1q containing DISC1 and DISC2 as a likely susceptibility locus for both schizophrenia and affective disorders. These genes are thus implicated in the aetiology of major psychiatric disorders in several populations. Although the function of DISC1 was initially unknown, several recent reports have made significant progress towards understanding its role in the central nervous system. Intriguingly, all data obtained to date point towards an involvement in processes critical to neurodevelopment and function. DISC2 has not been studied in detail, but is likely to modulate DISC1 expression. Overall, it is clear from the combination of genetic and functional data that DISC1 and/or DISC2 are emerging as important factors in the molecular genetics of psychiatric illness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478311     DOI: 10.1080/07853890410033603

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  22 in total

Review 1.  Deletion polymorphism of Disc1 is common to all 129 mouse substrains: implications for gene-targeting studies of brain function.

Authors:  Steven J Clapcote; John C Roder
Journal:  Genetics       Date:  2006-06-04       Impact factor: 4.562

Review 2.  Non-coding RNAs in the nervous system.

Authors:  Mark F Mehler; John S Mattick
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

3.  RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder.

Authors:  N Akula; J Barb; X Jiang; J R Wendland; K H Choi; S K Sen; L Hou; D T W Chen; G Laje; K Johnson; B K Lipska; J E Kleinman; H Corrada-Bravo; S Detera-Wadleigh; P J Munson; F J McMahon
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

Review 4.  Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings.

Authors:  Rosalinda C Roberts
Journal:  Schizophr Bull       Date:  2006-11-30       Impact factor: 9.306

Review 5.  Clinical perspectives on the genetics of schizophrenia: a bottom-up orientation.

Authors:  Willem M A Verhoeven; Siegfried Tuinier
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 6.  Uncovering the roles of long noncoding RNAs in neural development and glioma progression.

Authors:  Alexander D Ramos; Frank J Attenello; Daniel A Lim
Journal:  Neurosci Lett       Date:  2015-12-28       Impact factor: 3.046

Review 7.  Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function.

Authors:  J L Knauss; T Sun
Journal:  Neuroscience       Date:  2013-01-18       Impact factor: 3.590

8.  Regulatory long non-coding RNAs and neuronal disorders.

Authors:  Jhumku D Kohtz; Emily G Berghoff
Journal:  Physiol Behav       Date:  2010-01-25

9.  lncRNA expression in the auditory forebrain during postnatal development.

Authors:  Yan Guo; Pan Zhang; Quanhu Sheng; Shilin Zhao; Troy A Hackett
Journal:  Gene       Date:  2016-08-18       Impact factor: 3.688

10.  DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms.

Authors:  Kenji Nakata; Barbara K Lipska; Thomas M Hyde; Tianzhang Ye; Erin N Newburn; Yukitaka Morita; Radhakrishna Vakkalanka; Maxim Barenboim; Yoshitatsu Sei; Daniel R Weinberger; Joel E Kleinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.